8-K - Milestone Pharmaceuticals Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events On January 6, 2026, the Company issued a press release announcing the acceptance of a Marketing Authorization Application by the European Medicines

Other Event

9.01

Financial Statements and Exhibits (d) Exhibits. Exhibit Number Description of Exhibit 99.1 Press Release dated January 6, 2026 104 Cover Page Interactive Data (

Exhibits Only

Source Document

Exhibits (2)

8-K

FORM 8-K

99.1

EXHIBIT 99.1